Skip to content
The Policy VaultThe Policy Vault

Zyclara (imiquimod) 2.5% cream — Blue Cross Blue Shield of Alabama

actinic (solar) keratoses of the face and/or scalp

Initial criteria

  • - Patient has an FDA-labeled indication
  • - Patient age is within FDA labeling or supported for the indication
  • - Diagnosis of actinic (solar) keratoses of the face and/or scalp
  • - Requested agent is one of the listed drugs